Peptide Based Vaccine Strategies


Creative Commons License

AYDIN S., VARAN G., ÜNAL S.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.27, sa.2, ss.189-195, 2022 (ESCI, TRDizin) identifier identifier

Özet

Synthetic peptides are easy tool to investigate binding capacities, proteolytic activities and immunogenicity properties of proteins. They enable the development of vaccine candidates that can create a specific protective immune response by stimulating both cellular and humoral immunity with the B and T cell epitopes determined based on the nucleotide/amino acid sequence data of the pathogens. Although they are safe, biocompatible, and cost-effective, they have low immunogenicity capacities and are susceptible to enzymatic degradation. Effective and stable vaccines can be developed by increasing the immunogenicity capacities of synthetic peptides with a multiepitope approach and an appropriate adjuvant/carrier system.